S. Bates

发表

Specific loss of apoptotic but not cell‐cycle arrest function in a human tumor derived p53 mutant.

M. Oren, K. Vousden, S. Rowan, 1996, The EMBO journal.

Perturbation of the p53 response by human papillomavirus type 16 E7

K. Vousden, S. Bates, E. Hickman, 1997, Journal of virology.

The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2

Kevin Ryan, G. Peters, K. Vousden, 1998, The EMBO journal.

p14ARF links the tumour suppressors RB and p53

Karen H. Vousden, G. Peters, K. Vousden, 1998, Nature.

Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein.

L. Bonetta, G. Peters, K. Vousden, 1994, Oncogene.

E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways.

K. Vousden, S. Bates, A. Phillips, 1999, Molecular cell.

Characterisation of human cyclin G1 and G2: DNA damage inducible genes.

K. Vousden, S. Rowan, S. Bates, 1996, Oncogene.

Reversal of p53‐induced cell‐cycle arrest

K. Vousden, S. Bates, E. Hickman, 1999, Molecular carcinogenesis.

Cyclin D1 as a cellular proto-oncogene.

G. Peters, S. Bates, 1995, Seminars in cancer biology.

Accumulation of p16INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status

G. Peters, S. Bates, E. Hara, 1997, Oncogene.

Mechanisms of p53-mediated apoptosis

K. Vousden, S. Bates, 1999, Cellular and Molecular Life Sciences CMLS.

Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression

K. Vousden, S. Bates, A. Phillips, 1998, Oncogene.

Lack of cyclin D‐Cdk complexes in Rb‐negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product.

G. Peters, S. Bates, D. Mann, 1995, The EMBO journal.

CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1.

L. Bonetta, G. Peters, S. Bates, 1994, Oncogene.

INK4a‐deficient human diploid fibroblasts are resistant to RAS‐induced senescence

G. Peters, K. Vousden, S. Bates, 2002, The EMBO journal.

p53 in signaling checkpoint arrest or apoptosis.

K. Vousden, S. Bates, 1996, Current opinion in genetics & development.

Induction of DNA synthesis and apoptosis are separable functions of E2F-1.

K. Helin, K. Vousden, S. Bates, 1997, Genes & development.

Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins.

G. Peters, S. Bates, G Peters, 1995, Oncogene.

Mdm2 binds p73α without targeting degradation

K. Vousden, S. Bates, E. Balint, 1999, Oncogene.

Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function

K. Vousden, R. Ludwig, S. Bates, 1996, Molecular and cellular biology.

Mdm2 binds p73 alpha without targeting degradation.

K. Vousden, S. Bates, E. Balint, 1999, Oncogene.

Characterization of the human HCN1 channel and its inhibition by capsazepine

C. Davies, P. Murdock, D. Owen, 2004, British journal of pharmacology.